BBA
TYRA icon

Baker Bros. Advisors’s Tyra Biosciences TYRA Stock Holding History

Baker Bros. Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$406K Hold
10,607
– – ﹤0.01% 83
2025
Q4 		$279K Hold
10,607
– – ﹤0.01% 84
2025
Q3 		$148K Hold
10,607
– – ﹤0.01% 88
2025
Q2 		$102K Hold
10,607
– – ﹤0.01% 86
2025
Q1 		$98.6K Hold
10,607
– – ﹤0.01% 86
2024
Q4 		$147K Hold
10,607
– – ﹤0.01% 94
2024
Q3 		$249K Hold
10,607
– – ﹤0.01% 92
2024
Q2 		$170K Hold
10,607
– – ﹤0.01% 94
2024
Q1 		$174K Hold
10,607
– – ﹤0.01% 86
2023
Q4 		$147K Buy
+10,607
New +$137K ﹤0.01% 83

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Baker Bros. Advisors's TYRA Position: Q1 2026 in Review

Baker Bros. Advisors held its Tyra Biosciences (TYRA) position steady in Q1 2026 at 10,607 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #83.

Baker Bros. Advisors first reported a position in TYRA in Q4 2023 and has held it in 10 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Baker Bros. Advisors held 10,607 shares of Tyra Biosciences worth $406K as of Q1 2026.
  • Baker Bros. Advisors left its Tyra Biosciences share count unchanged in Q1 2026.
  • Tyra Biosciences made up ﹤0.01% of Baker Bros. Advisors's portfolio in Q1 2026, its #83 holding.
  • Baker Bros. Advisors first reported a position in Tyra Biosciences in Q4 2023 and has held it in 10 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Baker Bros. Advisors's 13F filing for Q1 2026, filed 15 May 2026.